RA
ABBV icon

Riversedge Advisors’s AbbVie ABBV Stock Holding History

Riversedge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
4,666
+65
+1% +$14K 0.15% 60
2026
Q1 		$1M Sell
4,601
-128
-3% -$28.4K 0.16% 57
2025
Q4 		$1.08M Buy
4,729
+200
+4% +$45.6K 0.18% 47
2025
Q3 		$1.05M Buy
4,529
+756
+20% +$154K 0.18% 49
2025
Q2 		$700K Buy
3,773
+96
+3% +$17.8K 0.14% 52
2025
Q1 		$770K Buy
3,677
+38
+1% +$7.39K 0.17% 52
2024
Q4 		$647K Buy
3,639
+84
+2% +$15.4K 0.15% 52
2024
Q3 		$702K Buy
3,555
+85
+2% +$15.9K 0.16% 48
2024
Q2 		$595K Sell
3,470
-9
-0.3% -$1.49K 0.15% 48
2024
Q1 		$633K Buy
3,479
+106
+3% +$18.3K 0.16% 44
2023
Q4 		$523K Sell
3,373
-326
-9% -$47.5K 0.14% 48
2023
Q3 		$551K Buy
3,699
+681
+23% +$100K 0.16% 45
2023
Q2 		$407K Buy
3,018
+4
+0.1% +$587 0.11% 51
2023
Q1 		$480K Buy
3,014
+383
+15% +$58.6K 0.14% 51
2022
Q4 		$425K Buy
2,631
+131
+5% +$20.1K 0.14% 54
2022
Q3 		$336K Hold
2,500
– – 0.12% 60
2022
Q2 		$383K Hold
2,500
– – 0.14% 53
2022
Q1 		$405K Sell
2,500
-58
-2% -$8.43K 0.13% 50
2021
Q4 		$346K Buy
2,558
+58
+2% +$6.85K 0.11% 55
2021
Q3 		$270K Hold
2,500
– – 0.09% 53
2021
Q2 		$282K Hold
2,500
– – 0.1% 44
2021
Q1 		$271K Hold
2,500
– – 0.12% 39
2020
Q4 		$268K Hold
2,500
– – 0.12% 41
2020
Q3 		$219K Hold
2,500
– – 0.12% 44
2020
Q2 		$245K Buy
+2,500
New +$220K 0.14% 36

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Riversedge Advisors's ABBV Position: Q2 2026 in Review

Riversedge Advisors increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $14K and bringing the position to 4,666 shares worth $1.17M. The position accounts for 0.15% of the portfolio, ranked #60.

Riversedge Advisors first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Riversedge Advisors held 4,666 shares of AbbVie worth $1.17M as of Q2 2026.
  • Riversedge Advisors bought 65 AbbVie shares in Q2 2026, an estimated $14K.
  • AbbVie made up 0.15% of Riversedge Advisors's portfolio in Q2 2026, its #60 holding.
  • Riversedge Advisors first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.